CMC 001

Drug Profile

CMC 001

Alternative Names: CMC-001

Latest Information Update: 09 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CMC Contrast
  • Class Contrast media; Heavy metals
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver disorders
  • New Molecular Entity No

Highest Development Phases

  • No development reported Liver disorders

Most Recent Events

  • 09 Feb 2016 No development reported - Phase-II for Liver disorders (Diagnosis) in USA (PO)
  • 27 Nov 2013 No development reported - Phase-III for Liver disorders in Sweden (PO)
  • 27 Nov 2013 Phase-II clinical trials in Diagnostic imaging in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top